Product Details:
Payment & Shipping Terms:
|
| PURITY: | 99% | APPEARANCE: | PALE YELLOW POWDER |
|---|---|---|---|
| MF: | C28H33N7O2 | MP: | 228-230 °C |
| BP: | 614.3 °C At 760 MmHg | CAS NO.: | 1421373-65-0 |
| High Light: | Pharma Raw Materials,raw pharmaceutical materials |
||
Antineoplastic Agents Pharmaceutical Raw Materials AZD9291 CAS 1421373-65-0
Product details:
AZD9291 a third-generation orally irreversible epidermal growth factor receptor (EGFR) inhibitor, is under development by British drug maker AstraZeneca for the treatment of patients with metastatic EGFR T790M mutation-positive non-small cell lung cancer (NSCLC).
Biological Activity:
AZD-9291 is an irreversible inhibitor of mutant EGFR kinase with IC50 values of 15nM, 17nM and 480nM, respectively for L858R/T790M, ex19del and wild-type EGFR.
Purity:99%min
Singel impurity:0.1%max
Related products:
| Tofacitinib Citrate | CAS NO.540737-29-9 |
| Posaconazole | CAS NO.171228-49-2 |
| ramelteon | CAS NO.196597-26-9 |
| sofosbuvir | CAS NO.1190307-88-0 |
| daclatasvir | CAS NO.1009119-65-6 |
| ledipasvir | CAS NO.1256388-51-8 |
| asunaprevir | CAS NO.630421-48-6 |
| vorapaxar | CAS NO.618385-01-6 |
| vildagliptin | CAS NO.274901-16-5 |
Contact Person: Jerry
Tel: +8615827051195
